• Health & Medicine

Life-extending immunotherapy approved on NHS for children with neuroblastoma

Children in England with high-risk neuroblastoma will now be offered a cancer drug that could extend their life. Children in England with high-risk neuroblastoma will now be offered a cancer drug that could extend their life.

13 July 2018

• Health & Medicine

Brain tumour surgery dye now available to more NHS patients

A chemical dye that lights up brain tumours during surgery should be available to more NHS patients in England, according to NICE. A chemical dye that lights up brain tumours during surgery should be available to more NHS patients in England, according to NICE.

12 July 2018

• Science & Technology

Teamwork between cells fuels aggressive childhood brain tumour

Scientists have discovered that cancerous cells in an aggressive type of childhood brain tumour work together to infiltrate the brain. Scientists have discovered that cancerous cells in an aggressive type of childhood brain tumour work together to infiltrate the brain.

2 July 2018

• Policy & Insight

Cancer Research UK responds to the Governments new Childhood Obesity Plan

Cancer Research UK responds to the Governments new Childhood Obesity Strategy. Cancer Research UK responds to the Governments new Childhood Obesity Strategy.

25 June 2018

• Health & Medicine

Number of elderly diagnosed with cancer set to rocket by 80% in less than 20 years

The number of older people diagnosed with cancer every year could rise by up to 80% to nearly a quarter of a million by 2035, according to new figures. The number of older people diagnosed with cancer every year could rise by up to 80% to nearly a quarter of a million by 2035, according to new figures.

21 June 2018

• Health & Medicine

New drug halves hearing loss in children following cancer treatment

Giving the drug sodium thiosulphate after chemotherapy reduces hearing loss in children treated for liver cancer, according to new research. Giving the drug sodium thiosulphate after chemotherapy reduces hearing loss in children treated for liver cancer, according to new research.

20 June 2018

• Health & Medicine

Cancer Research UK tests first of its kind vaccine to treat lung cancer

A first of its kind treatment vaccine has moved into a phase I clinical trial for patients with non-small cell lung cancer. A first of its kind treatment vaccine has moved into a phase I clinical trial for patients with non-small cell lung cancer.

12 June 2018

• Charity News

Cancer Research UK announces new chief business officer

Cancer Research UK has appointed Tony Hickson as the charity’s new chief business officer. Cancer Research UK has appointed Tony Hickson as the charity’s new chief business officer.

8 June 2018

• Health & Medicine

Ex-smokers might be better off with high rather than low nicotine e-cigs

Vapers using low rather than high nicotine e-cigarettes may be using their devices more intensely, potentially increasing the risk of exposure to toxins. Vapers using low rather than high nicotine e-cigarettes may be using their devices more intensely, potentially increasing the risk of exposure to toxins.

8 June 2018

• Health & Medicine

Prostate cancer drug given initial ‘no’ for NHS in England

The prostate cancer drug abiraterone has been provisionally rejected as a first-line treatment on the NHS in England. The prostate cancer drug abiraterone has been provisionally rejected as a first-line treatment on the NHS in England.

7 June 2018

• Health & Medicine

Older breast cancer patients in England less likely to survive than in four other European countries

Older women diagnosed with breast cancer in England are less likely to survive their disease than those in Belgium, Poland, Ireland and the Netherlands. Older women diagnosed with breast cancer in England are less likely to survive their disease than those in Belgium, Poland, Ireland and the Netherlands.

7 June 2018

• Health & Medicine

Lung cancer immunotherapy drug approved for England

The lung cancer immunotherapy drug pembrolizumab has been made widely available on the NHS in England after a price deal was reached. The lung cancer immunotherapy drug pembrolizumab has been made widely available on the NHS in England after a price deal was reached.

6 June 2018